PMOS After Menopause: What This Study Suggests About Long-Term Metabolic Health

PMOS May Change Rather Than Disappear

During the reproductive years, PMOS is often recognised through symptoms such as:

• Irregular or absent periods
• Difficulty ovulating
• Acne
• Excess facial or body hair
• Hair thinning
• Fertility challenges

After menopause, periods and ovulation are no longer relevant markers. However, the metabolic features associated with PMOS may remain important.

The researchers describe PMOS as potentially shifting from a condition dominated by reproductive symptoms to one where body composition, blood sugar regulation, cardiovascular health, and long-term disease prevention become the greater focus.

Where Fat Is Stored May Matter More Than Total Body Fat

One of the clearest findings involved body fat distribution.

The women with PMOS did not have significantly more total body fat, trunk fat, or measured visceral fat than the women without PMOS. However, a greater proportion of their fat was carried around the trunk compared with the arms and legs.

In simple terms, the overall amount of body fat was similar, but its distribution was different.

Carrying more fat centrally around the torso is associated with a greater risk of:

• Insulin resistance
• Type 2 diabetes
• High blood pressure
• Unhealthy cholesterol patterns
• Metabolic syndrome
• Cardiovascular disease

This suggests that where the body stores fat may provide important information that is not always visible through weight alone.

Body Weight Did Not Tell The Whole Story

The women with PMOS had a significantly higher average BMI. They also tended to have a higher waist-to-hip ratio, although this second finding did not reach statistical significance.

However, there were no significant differences between the groups in:

• Body weight
• Waist circumference
• Hip circumference
• Total fat mass
• Lean muscle mass
• Percentage body fat

This is important because two women can have a similar weight or total amount of body fat while carrying that fat very differently.

It also reinforces that body weight should not be used as the only measure of metabolic health. Waist measurements, body fat distribution, blood markers, medical history, and other individual risk factors all contribute to the broader picture.

Many Standard Blood Markers Were Similar

The researchers did not find significant differences between the groups in most of the blood markers they measured.

These included:

• Fasting glucose
• Fasting insulin
• HbA1c, which reflects longer-term blood sugar levels
• LDL cholesterol
• HDL cholesterol
• Triglycerides
• Blood pressure
• Inflammatory markers
• Testosterone and other sex hormones

Total cholesterol was lower in the PMOS group, but this isolated finding should be interpreted carefully because of the small number of participants and the possible influence of prescription medications.

The lack of differences does not necessarily mean that the two groups had identical metabolic health. It may mean that their current treatment, lifestyle, or medication use was helping to control the markers measured during the study.

Medication Use May Have Influenced The Results

The women with PMOS tended to report using more prescription medications, although the difference between groups narrowly missed statistical significance.

Every woman with PMOS who completed the medication questionnaire reported taking at least one prescription medication. In comparison, more than one-third of the women without PMOS reported taking no prescription medications.

Three of the nine women with PMOS who provided medication information were taking five or more prescription medications.

The most frequently reported medication categories across the study included:

• Cardiovascular medications
• Blood glucose regulators
• Antidepressants
• Thyroid hormone medications
• Anti-anxiety medications

These treatments may have helped manage blood pressure, glucose, cholesterol, mood, and other health indicators. This could partly explain why many of the blood results appeared similar between the groups.

Good Blood Results Do Not Always Mean There Is No Underlying Risk

A blood test provides information about what is happening at one point in time. It does not always reveal how much support or treatment is required to keep those results within a healthy range.

For example, similar glucose or cholesterol levels may reflect:

• Different levels of prescription medication use
• Previous lifestyle changes
• Differences in healthcare access
• Existing treatment for metabolic conditions
• Other factors that were not measured in the study

This means it is important to consider the wider context rather than looking at one blood result in isolation.

For women with PMOS, a healthy result is still positive. However, it should not automatically be interpreted as evidence that ongoing metabolic screening is no longer needed.

Multiple Medications Deserve Regular Review

Taking five or more medications is commonly described as polypharmacy.

Medications can be essential and highly beneficial, but the use of multiple prescriptions can increase the risk of:

• Medication interactions
• Side effects
• Confusion around timing and dosage
• One medication affecting the action of another
• A greater overall treatment burden

The study does not suggest that women should stop taking prescribed medications. Instead, it highlights the importance of regular medication reviews, particularly when several healthcare providers are involved.

It may also be useful for healthcare professionals to consider how medication, nutrition, physical activity, sleep, stress support, and other lifestyle strategies can work together.

Mood, Sleep And Quality Of Life Were Not Significantly Different

The researchers also assessed:

• Depression
• Anxiety
• Fatigue
• Sleep disturbance
• Sleep-related impairment
• Social participation
• Satisfaction with social roles and activities

They did not find significant differences between women with and without PMOS.

However, this should not be interpreted as proof that the experiences of both groups were identical. The study was very small, and the use of antidepressant and anti-anxiety medications may also have influenced the results.

Larger studies are needed to understand how PMOS affects mental health, sleep, fatigue, and quality of life after menopause.

There May Be A Gap In Care After The Reproductive Years

Women with PMOS are often supported by gynaecologists, fertility specialists, or reproductive endocrinologists during their reproductive years.

Once fertility and menstrual health are no longer the focus, it may become unclear which healthcare professional is responsible for monitoring the longer-term effects of PMOS.

This creates the risk that important areas of health may receive less attention, including:

• Blood sugar regulation
• Blood pressure
• Cholesterol and cardiovascular risk
• Central fat distribution
• Liver health
• Medication management
• Mental health and quality of life

The researchers call for earlier prevention, more consistent screening, improved education, and care that continues across the lifespan.

This Was A Small And Early Study

This research offers useful insights, but its limitations are important.

The study included only 29 women, with just 10 in the PMOS group. The PMOS participants were all white, and their previous diagnoses could not be confirmed through medical records.

The researchers also did not assess:

• Diet
• Physical activity
• The reason each medication was prescribed
• Previous medication use
• Different PMOS phenotypes or presentations
• Changes in health over time

Because this was a cross-sectional study, it captured one point in time. It cannot prove that PMOS directly caused the differences in body fat distribution or medication use.

The findings should therefore be treated as preliminary rather than definitive.

What This Means For Women With PMOS

This study supports the idea that PMOS is not only a reproductive condition.

Even after periods and ovulation have ended, women with a history of PMOS may continue to have differences in body fat distribution and may require more medical treatment to manage their health.

Perhaps the most valuable message is that PMOS care should not end at menopause.

The focus may simply need to change from managing cycles and fertility to supporting:

• Metabolic health
• Cardiovascular health
• Healthy body composition
• Blood sugar regulation
• Medication management
• Long-term quality of life

Ongoing screening and preventive care can help identify changes early and ensure that women continue to receive appropriate support throughout every life stage.